STOCK TITAN

Dyne Therapeutics, Inc. (DYN) Net Income by Year

DYN

Dyne Therapeutics, Inc. reported a net loss of $446 in fiscal year 2025. This represents a decrease of 40.6% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Dyne Therapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$446
YoY -40.6%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

DYN Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY22DEF 14AFY2110-KFY2010-KFY1910-K
Net Income-$446-40.6%-$317-34.5%-$236-40.3%-$168+100.0%-$149.3M-151.2%-$59.4M-300.0%-$14.9M

DYN Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$178.6M-61.1%-$120.9M-4.8%N/A-$108.0M-11.2%-$110.9M-70.3%-$115.4M-75.7%N/A-$97.1M-61.3%-$65.1M-0.3%-$65.6M-48.6%N/A-$60.2M-45.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Dyne Therapeutics, Inc. financials

Frequently Asked Questions

What was Dyne Therapeutics, Inc.'s net income in fiscal year 2025?

Dyne Therapeutics, Inc. reported a net loss of $446 in fiscal year 2025.

How fast is Dyne Therapeutics, Inc.'s net income growing?

Dyne Therapeutics, Inc. (DYN) net income fell by 40.6% year over year, from -$317 to -$446 in fiscal year 2025.

How has Dyne Therapeutics, Inc.'s net income changed over the years?

Across the 7 fiscal years this page covers, Dyne Therapeutics, Inc. (DYN) net income went from -$14.9M in fiscal year 2019 to -$446 in fiscal year 2025.

Dyne Therapeutics, Inc. (DYN) reported -$178.6M in net income in Q2 2026. This represents a decrease of 61.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Dyne Therapeutics, Inc. (DYN) reported on that line in every period on record.